Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Enid and George - Life with dementia

social support1 - pfizer1 - frontotemporal lobar degeneration4 - cause of alzheimer's1 - lewy body parkinson's disease1 - the gerontologist1 - simplicity1 - hiv-infected1 - learning skills1 - coronary artery1 - alzheimer2 - abeta1 - cardiovascular disease1 - caregiving2 - cognitive1 - wernicke’s encephalopathy1 - alzheimer's treatments3 - aggression or irritability1 - numeracy1 - alzheimers and parkinsons1 - gray matter1 - electroencephalogram1 - vascular damage1 - neuronal membrane1 - memory loss20 - mirna1 - amnestic mild cognitive impairment1 - huntington's disease8 - alzheimer's society2 - loss of balance1 -